FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lee Lancashire

Research Profile

Activities & Behaviors

Neural Networks (Computer)

Chemicals & Drugs

Anatomy

Circulating Neoplastic Cells

Occupations

Procedures

Concepts & Ideas

Disorders

Devices

Protein Array Analysis

Co-author Network

Publications

TOP 3
Cong Zhou; Martin J Dawson; Caroline Dive; Lee Lancashire; Patricia Price; Agata Rembielak; Kathryn L Simpson; Richard D Unwin; Michael J Walker; Catharine West; Anthony D Whetton
Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery.
Jian-Mei Hou; Matthew G Krebs; Lee Lancashire; Karen Morris; Lynsey J C Priest; Robert Sloane; Rajeeb K Swain; Tim Ward; Cong Zhou; Alison Backen; Fiona H Blackhall; Alastair Greystoke; Caroline Dive
Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Matthew G Krebs; Lee Lancashire; Daisuke Nonaka; Lynsey Priest; Malcolm Ranson; Robert Sloane; Tim Ward; Alison Backen; Fiona H Blackhall; Glen Clack; Jian-Mei Hou; Andrew Hughes; Caroline Dive
Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lee Lancashire (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Cong Zhou; Martin J Dawson; Caroline Dive; Lee Lancashire; Patricia Price; Agata Rembielak; Kathryn L Simpson; Richard D Unwin; Michael J Walker; Catharine West; Anthony D Whetton
Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery.
Journal of proteome research 2012;11(4):2103-13.
2012: Jian-Mei Hou; Matthew G Krebs; Lee Lancashire; Karen Morris; Lynsey J C Priest; Robert Sloane; Rajeeb K Swain; Tim Ward; Cong Zhou; Alison Backen; Fiona H Blackhall; Alastair Greystoke; Caroline Dive
Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(5):525-32.
2012: Matthew G Krebs; Lee Lancashire; Daisuke Nonaka; Lynsey Priest; Malcolm Ranson; Robert Sloane; Tim Ward; Alison Backen; Fiona H Blackhall; Glen Clack; Jian-Mei Hou; Andrew Hughes; Caroline Dive
Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(2):306-15.
2011: Matthew G Krebs; Robert Sloane; Lynsey Priest; Lee Lancashire; Jian-Mei Hou; Alastair Greystoke; Tim Ward; Roberta Ferraldeschi; Andrew Hughes; Glen Clack; Malcolm Ranson; Caroline Dive; Fiona H Blackhall
Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(12):1556-63.
2011: Lee Lancashire; Darren L Roberts; Caroline Dive; Andrew G Renehan
The development of composite circulating biomarker models for use in anticancer drug clinical development.
International journal of cancer. Journal international du cancer 2011;128(8):1843-51.
2010: Lee Lancashire; D G Powe; Jorge S Reis-Filho; E Rakha; C Lemetre; B Weigelt; T M Abdel-Fatah; Andrew Green; R Mukta; R Blamey; E C Paish; R C Rees; Ian O Ellis; G R Ball
A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks.
Breast cancer research and treatment 2010;120(1):83-93.
2009: Joshua Boateng; Richard Kay; Lee Lancashire; Pamela Brown; Cristiana Velloso; Pierre Bouloux; Phil Teale; Jane Roberts; Robert Rees; Graham Ball; Stephen D R Harridge; Geoffrey Goldspink; Colin S Creaser
A proteomic approach combining MS and bioinformatic analysis for the detection and identification of biomarkers of administration of exogenous human growth hormone in humans.
Proteomics. Clinical applications 2009;3(8):912-22.
2009: Jian-Mei Hou; Alastair Greystoke; Lee Lancashire; Jeff Cummings; Tim Ward; Ruth Board; Eitan Amir; Sarah Hughes; Matthew Krebs; Andrew Hughes; Malcolm Ranson; Paul Lorigan; Caroline Dive; Fiona H Blackhall
Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy.
The American journal of pathology 2009;175(2):808-16.
2009: Lee Lancashire; Christophe Lemetre; Graham R Ball
An introduction to artificial neural networks in bioinformatics--application to complex microarray and mass spectrometry datasets in cancer studies.
Briefings in bioinformatics 2009;10(3):315-29.
2008: Esther C de Haas; Alessandra di Pietro; Kathryn L Simpson; Coby Meijer; Albert J H Suurmeijer; Lee Lancashire; Jeff Cummings; Steven de Jong; Elisabeth G E de Vries; Caroline Dive; Jourik A Gietema
Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
Neoplasia (New York, N.Y.) 2008;10(10):1041-8.
2008: Lee Lancashire; Robert C Rees; Graham R Ball
Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
Artificial intelligence in medicine 2008;43(2):99-111.
2008: Andrew J K Williamson; Duncan Smith; David Blinco; Richard D Unwin; Stella Pearson; Claire Wilson; Crispin Miller; Lee Lancashire; Georges Lacaud; Valerie Kouskoff; Anthony D Whetton
Quantitative proteomics analysis demonstrates post-transcriptional regulation of embryonic stem cell differentiation to hematopoiesis.
Molecular & cellular proteomics : MCP 2008;7(3):459-72.
2007: Balwir Matharoo-Ball; C Hughes; Lee Lancashire; David Tooth; Graham Ball; Colin S Creaser; M Elgasim; Robert Rees; Robert Layfield; William Atiomo
Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms.
Journal of proteome research 2007;6(8):3321-8.
2007: Balwir Matharoo-Ball; Lucy Ratcliffe; Lee Lancashire; Selma Ugurel; Amanda K Miles; Daniel J Weston; Robert Rees; Dirk Schadendorf; Graham Ball; Colin S Creaser
Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI-TOF mass spectrometry/bioinformatic approach.
Proteomics. Clinical applications 2007;1(6):605-20.
2006: Carol Iversen; Lee Lancashire; Michael Waddington; Stephen Forsythe; Graham Ball
Identification of Enterobacter sakazakii from closely related species: the use of artificial neural networks in the analysis of biochemical and 16S rDNA data.
BMC microbiology 2006;6():28.
2005: Oliver Schmid; Graham Ball; Lee Lancashire; Renata Culak; Haroun Shah
New approaches to identification of bacterial pathogens by surface enhanced laser desorption/ionization time of flight mass spectrometry in concert with artificial neural networks, with special reference to Neisseria gonorrhoeae.
Journal of medical microbiology 2005;54(Pt 12):1205-11.
2005: Shahid Mian; Selma Ugurel; Erika Parkinson; Iris Schlenzka; Ian Dryden; Lee Lancashire; Graham Ball; Colin S Creaser; Robert Rees; Dirk Schadendorf
Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5088-93.
2005: Lee Lancashire; O Schmid; H Shah; Graham Ball
Classification of bacterial species from proteomic data using combinatorial approaches incorporating artificial neural networks, cluster analysis and principal components analysis.
Bioinformatics (Oxford, England) 2005;21(10):2191-9.